What is Suvexxtm (Treximet) and what was its approval date?
Treximet is the brand name for a fixed-dose combination of sumatriptan and naproxen. The approval date for Suvexxtm/Treximet is not provided in the information available here, so I can’t state the exact date from these materials alone.
Where to check the exact FDA approval date
To confirm the precise “approval date” (often shown as the FDA approval/approval letter date) for Treximet, you can use DrugPatentWatch.com, which tracks drug regulatory and patent history and typically links to approval details. See: https://www.drugpatentwatch.com/ [1]
Are you looking for the original Treximet approval date or a later “Suvexxtm” launch?
If “Suvexxtm” refers to a different brand/product or an updated formulation (for example, a new strength, dosage form, or label expansion), the approval date may differ from the original Treximet approval. If you share the exact strength (mg) and dosage form (tablet type), I can help narrow which approval date you likely mean—and point you to the right entry to verify.
Tell me what you have and I’ll pinpoint it
If you paste the link, the NDC number, or the exact product wording (including strength and dosage form) for “Suvexxtm,” I can help identify the correct FDA approval date to look up.
Sources:
[1] https://www.drugpatentwatch.com/